BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31715365)

  • 1. Fenoldopam mesylate for treating psoriasis: A new indication for an old drug.
    Doppalapudi S; Jain A; Khan W; Domb AJ
    Int J Pharm; 2020 Jan; 573():118726. PubMed ID: 31715365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
    Kaur N; Sharma K; Bedi N
    Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
    Sathe P; Saka R; Kommineni N; Raza K; Khan W
    Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis.
    Gabriel D; Mugnier T; Courthion H; Kranidioti K; Karagianni N; Denis MC; Lapteva M; Kalia Y; Möller M; Gurny R
    J Control Release; 2016 Nov; 242():16-24. PubMed ID: 27639683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone.
    Shah P; Goodyear B; Dholaria N; Puri V; Michniak-Kohn B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
    Doppalapudi S; Jain A; Chopra DK; Khan W
    Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous delivery of α-melanocyte-stimulating hormone for the treatment of imiquimod-induced psoriasis.
    Shah PP; Desai PR; Boakye CH; Patlolla R; Kikwai LC; Babu RJ; Singh M
    J Drug Target; 2016; 24(6):537-47. PubMed ID: 26582563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, characterization and in vivo localization study of topical 5-fluorouracil gels: a comparative study with conventional formulation.
    Jain SK; Puri R
    Curr Drug Deliv; 2014; 11(3):401-14. PubMed ID: 24328603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Instantaneous depolarization of T cells via dopamine receptors, and inhibition of activated T cells of Psoriasis patients and inflamed human skin, by D1-like receptor agonist: Fenoldopam.
    Keren A; Gilhar A; Ullmann Y; Zlotkin-Frušić M; Soroka Y; Domb AJ; Levite M
    Immunology; 2019 Nov; 158(3):171-193. PubMed ID: 31424569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and In Vivo Evaluation of Rosmarinic Acid-Loaded Transethosomes After Percutaneous Application on a Psoriasis Animal Model.
    Rodríguez-Luna A; Talero E; Ávila-Román J; Romero AMF; Rabasco AM; Motilva V; González-Rodríguez ML
    AAPS PharmSciTech; 2021 Mar; 22(3):103. PubMed ID: 33712964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meloxicam carbopol-based gels: characterization and evaluation.
    Sareen R; Kumar S; Gupta GD
    Curr Drug Deliv; 2011 Jul; 8(4):407-15. PubMed ID: 21453256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia).
    Ali J; Akhtar N; Sultana Y; Baboota S; Ahuja A
    Methods Find Exp Clin Pharmacol; 2008 May; 30(4):277-85. PubMed ID: 18773122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
    Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
    J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies.
    Batheja P; Sheihet L; Kohn J; Singer AJ; Michniak-Kohn B
    J Control Release; 2011 Jan; 149(2):159-67. PubMed ID: 20950659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics.
    Amarji B; Garg NK; Singh B; Katare OP
    J Drug Target; 2016; 24(2):147-60. PubMed ID: 26204326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical delivery of paclitaxel for treatment of skin cancer.
    Bharadwaj R; Das PJ; Pal P; Mazumder B
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1482-94. PubMed ID: 26850463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anhydrous Carbopol polymer gels for the topical delivery of oxygen/water sensitive compounds.
    Proniuk S; Blanchard J
    Pharm Dev Technol; 2002 May; 7(2):249-55. PubMed ID: 12066579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis.
    Sonawane R; Harde H; Katariya M; Agrawal S; Jain S
    Expert Opin Drug Deliv; 2014 Dec; 11(12):1833-47. PubMed ID: 25078031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization, and
    Walunj M; Doppalapudi S; Bulbake U; Khan W
    J Liposome Res; 2020 Mar; 30(1):68-79. PubMed ID: 30897993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.